2024 - Bridging the Gap: Direct-to-Patient Strategies to Support Diversity in Clinical Trials
Date2024-09-26
Deadline2024-09-26
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Clinical Trials; Patient Recruitment & Retention
Topics/Call fo Papers
This webinar will explore the latest trends in the clinical trial industry, emphasizing direct-to-patient trial strategies and their impact on diversity, equity and inclusion (DEI). Reaching marginalized communities is a critical component for fulfilling study enrollment, yet these communities often face unique challenges.
One significant hurdle is the financial burden placed on patients due to the leveraging of patient insurance, which can hinder study enrollment and impact efforts to improve clinical trial diversity in the United States. Current industry trends are centered on patient-centric approaches such as DEI, accelerated start-up timelines and decentralized clinical trials.
Prioritizing patient-centricity can significantly enhance patient experience and enrollment, leading to more successful clinical trials. In addition, as clinical trial sites manage numerous studies simultaneously, it is essential to develop supply strategies that simplify the management of investigational medicinal products (IMPs) and non-IMPs (NIMPs).
This webinar will dive into how patient-centric supply strategies can address these complexities, improve trial efficiency and support clinical trial diversity. Through case studies, the featured speakers will examine various sourcing options for sponsors, highlighting their benefits and drawbacks for sponsors, patients and sites. Additionally, the discussion will cover how comparator drug supply vendors handle complex trial designs and access to specialty drugs, ensuring that patient needs are met efficiently.
Register for this webinar to learn about innovative, on-demand local sourcing solutions, methods to minimize cost and waste in clinical trials and how clinical trial diversity can benefit both sites and patients.
Keywords: Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Patient Diversity, Clinical Trial Diversity, Diversity and Inclusion, Diversity and Inclusion in Clinical Trials, Sites, Supply Chain/Logistics, CT Logistics, DEI
One significant hurdle is the financial burden placed on patients due to the leveraging of patient insurance, which can hinder study enrollment and impact efforts to improve clinical trial diversity in the United States. Current industry trends are centered on patient-centric approaches such as DEI, accelerated start-up timelines and decentralized clinical trials.
Prioritizing patient-centricity can significantly enhance patient experience and enrollment, leading to more successful clinical trials. In addition, as clinical trial sites manage numerous studies simultaneously, it is essential to develop supply strategies that simplify the management of investigational medicinal products (IMPs) and non-IMPs (NIMPs).
This webinar will dive into how patient-centric supply strategies can address these complexities, improve trial efficiency and support clinical trial diversity. Through case studies, the featured speakers will examine various sourcing options for sponsors, highlighting their benefits and drawbacks for sponsors, patients and sites. Additionally, the discussion will cover how comparator drug supply vendors handle complex trial designs and access to specialty drugs, ensuring that patient needs are met efficiently.
Register for this webinar to learn about innovative, on-demand local sourcing solutions, methods to minimize cost and waste in clinical trials and how clinical trial diversity can benefit both sites and patients.
Keywords: Clinical Research, Patient-Centricity, CRO, Patient Recruitment, Patient Diversity, Clinical Trial Diversity, Diversity and Inclusion, Diversity and Inclusion in Clinical Trials, Sites, Supply Chain/Logistics, CT Logistics, DEI
Other CFPs
- Novel Liquid Biopsy ML multigene mRNA Expression for Clinical Trials: from Discovery to CDx Development
- Key Pathology Considerations for Successful Preclinical Medical Device Studies, from Protocol to Report
- Improving Hospital Capacity Using Care-at-Home Strategies
- Digital Health Tools That Will Transform Cancer Treatment
- Spatial Visualization of Capsid-Dependent Viral Tropism using RNAscope ISH Technology
Last modified: 2024-09-17 05:12:05